Thursday, 7 January 2021

EU Stoxx 50 May Fall Despite Approval of Moderna Covid-19 Vaccine

Europe’s benchmark EU Stoxx 50 index may lose ground in the coming days despite the regulatory approval of Moderna’s Covid-19 vaccine as price runs into key resistance.

from DailyFX - Market News https://ift.tt/3hMqK4E
via IFTTT
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

ECB Leaves Rates Unchanged, Rate Cut Looms, EUR/USD Steady Ahead of Press Conference

The European Central Bank left all three official rates unchanged as expected. Traders are now focusing on the press conference for any clue...